No abstract available.
Pancreatitis, Chronic* ; Pathology*

No abstract available.
Diagnosis* ; Humans ; Low Back Pain*

No abstract available.
Diagnosis* ; Humans ; Low Back Pain*

The isoimmune hemolytic disease of newborn due to the minor blood groups is characterized by the progressive neonatal hyperbilirubinemia and anemia. This is caused by the lgG antibody transmitted from the mother to the fetus across the placenta. ABO and Rho(D) incompatability have been the most common antibody responsible for hemolytic disease of newborn. But recently the incidence of the Rho(D) incompatability is decreased due to the prophylaxis of anti-D immunoglobulin for the Rh negative mother and that of the incompataibility of minor blood group seems to be increased. This report presents the clinical and hematologic features of four cases of hemolytic diseases of newborn due to minor blood group isoimmunization who were admitted to the Dong-guk University Kyung-ju Hospital. The following results were obtained; 1) Neontal hyperbilirubinemia was observed within 48 hours after birth in all cases of patients and disappeared with the treatment of exchange transfusion and phototherapy. 2) Total bilirubin levels were 6.7-24.8 mg/dl. 3) Direct Coombs' test was positive in all cases of patients and indirect Coombs' test was positive except case 3. Direct Coombs' test was negative and indirect Coombs' test was positive in all mothers. 4) There was no evidence of ABO or Rh(D) incompatibility in all cases of patients. Case 1, 2 and 4 had the hemolytic diseases of newborn due to anti-E isoimmunization anti-E, but case 3 had the hemolytic diseases of newborn due to anti-C isoimmunization. 5) According to the reports which was published to date, 23 cases of the hemolytic diseases of newborn due to minor blood group isoimmunization were revealed; 14 anti-E, 4 anti-c, 1 anthE or c, 1 anti-C, 1 anti-e, 1 anti-M, and 1 anti-Kidd. Therefore we can easily conclude that anti-E is the most common cause of hemolytic diseases of newborn due to minor blood group isoimmunization in Korea. So, we report this case with the brief review of relevant literatures.
Anemia ; Bilirubin ; Blood Group Antigens ; Coombs Test ; Erythroblastosis, Fetal ; Fetus ; Gyeongsangbuk-do ; Humans ; Hyperbilirubinemia ; Hyperbilirubinemia, Neonatal ; Immunoglobulins ; Incidence ; Infant, Newborn ; Korea ; Mothers ; Parturition ; Phototherapy ; Placenta

No abstract available.
Influenza, Human*

OBJECTIVE: To compsre the efficiency, success rate, and abortion time of applications of intravaginal misoprostol versus prostaglandin E2 vaginal tablet for mid-trimester pregnancy termination Subjects and methods: Eighty four patients between 17-29 weeks of gestation with medical, obstetric, or genetic reasons far termination were randomized to receive either 50 ug tablets of misoprostol placed in the posterior vaginal fornix or prostaglandin E2 3mg in tables placed into the endocervix. RESULTS: Among eighty four patients recruited, fourty five patients received misoprostol and thirty nine patients received prostaglandin E2 vaginal tablets. The average interval hom start of induction to vaginal delivery was 13.35 +/- 3.34 hours in misoprostol poup and 19.14 +/- 10.64 hours in the prostaglandin E2 group. The success rate of complete termination within 12 and 24 hours in misopr-ostol group were 57.7%, 93.3%, respectively, while in prostaglandin E2 group were 20.5%, 82.1% repectively. Oxytocin augumentation was 6.7% in misoprostol group and 17.9% in the prostaglardin E2 group. No serious complication occumd. CONCLUSION: Intracervicovaginal misoprostol appears to be acceptably safe and effective agents for second trimester pregnancy termination. The abortion time is less in misoprostol group than those in the prostaglandin E2 group. Misoprostol has the advantage of being expensive, easily stored and readily available. We used 50 ug tablets of misoprostol every four hours. But, we suspect that the regimen of 100ug misopostol inserted intracervico-vaginally every eight hours will beis the proper and optimal method for pregnancy termination.
Dinoprostone* ; Female ; Humans ; Misoprostol* ; Oxytocin ; Pregnancy Trimester, Second ; Pregnancy* ; Tablets ; Vaginal Creams, Foams, and Jellies*

No abstract available.
Bioterrorism*

No abstract available.
Immunization*

No abstract available.

In modern society we have been gradually interested in the elderly and easily come into contact with many medical favors to enhance the quality of life, and the elderly are gradually increasing owing to the development of the basic science such as new diagnostic machinery, operative technique and development of the therapeutics. However, the variation of the environment has increased the possibility to be exposed to the dangerous factors, and it has given rise to the problems about the quality of the elderly life. It has also greatly enlarged in medical as well as social. Therefore, the frequency of the elderly reconstructive surgery to increase the quality of the elderly life by operation without life or death has increased in plastic surgery. So authors thought that the safe operative study is necessary. We reviewed the case of 102 elderly patients (65 years of age), who were operated during the period from 1988 to 1995, and analyzed the age & sex distribution, classification & distribution of diseases in elderly, operation of plastic & reconstructive surgery in elderly, anesthetic, methods, underlying diseases, and postoperative complications through the patient records. We also examined postoperative function, aesthetic improvement, progression of the quality of life by telephone and analyzed the elderly classification and elderly plastic & reconstructive surgery. The results are as follows : 1. There were benign neoplasm, facial bone fracture, aesthetic surgery, skin and soft tissue defect, complicated diabetic mellitus, malignant ulcer, malignant neoplasm, pressure sore in elderly diseases of plastic & reconstructive surgery. 2. We mainly performed skin graft, flap surgery, ORIF, aesthetic surgery. 3. The recovery rate after postoperative evaluation shows that ; 1) 52% of total interviewee feel that their QOL has improved. 2) 24% of total interviewee feel that their QOL has not changed. 3) 24% of total interviewee feel that their QOL has deteriorated. We report the point at issue and statistical examination with record investigation.
Aged* ; Classification ; Dermatologic Surgical Procedures ; Facial Neoplasms ; Fractures, Bone ; Humans ; Postoperative Complications ; Pressure Ulcer ; Quality of Life ; Sex Distribution ; Skin ; Surgery, Plastic* ; Telephone ; Transplants ; Ulcer